Page last updated: 2024-10-27

fluorouracil and Paraganglioma, Gangliocytic

fluorouracil has been researched along with Paraganglioma, Gangliocytic in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"Ten percent of paragangliomas are malignant and one-third occurs in a genetic background."5.38A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine. ( Borson-Chazot, F; Giraud, S; Joly, MO; Lombard-Bohas, C; Nozières, C; Riou, JP; Scoazec, JY; Simon, C; Walter, T, 2012)
"Ten percent of paragangliomas are malignant and one-third occurs in a genetic background."1.38A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine. ( Borson-Chazot, F; Giraud, S; Joly, MO; Lombard-Bohas, C; Nozières, C; Riou, JP; Scoazec, JY; Simon, C; Walter, T, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nozières, C1
Walter, T1
Joly, MO1
Giraud, S1
Scoazec, JY1
Borson-Chazot, F1
Simon, C1
Riou, JP1
Lombard-Bohas, C1

Other Studies

1 other study available for fluorouracil and Paraganglioma, Gangliocytic

ArticleYear
A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine.
    European journal of endocrinology, 2012, Volume: 166, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Dacarbazine;

2012